CONTEXT: Twist1 is a transcription factor implicated in the regulation of TNFα signaling and was recently shown to be highly expressed in both human and murine adipose tissue, but its role in obesity is unknown. OBJECTIVE: Our objective was to assess the expression of twist1 in human white adipose tissue (WAT), its relationship to obesity and insulin sensitivity, and how it modifies TNFα-mediated inflammation in adipocytes. PROCEDURE: Twist mRNA levels were measured in WAT from 130 nonobese and obese subjects, and its relation to clinical parameters was assessed. Twist1 expression was measured before and after weight loss as well as in different adipose regions. Human in vitro differentiated adipocytes were treated with TNFα under control conditions or after twist1 gene silencing by RNA interference. Gene expression and secretion of proinflammatory proteins were measured. RESULTS: Twist1 expression was low in obese subjects and increased after weight loss. Twist1 mRNA levels correlated with adiponectin levels and inversely with insulin resistance as well as adipocyte volume (P < 0.001 for all). Low twist1 expression associated with a hypertrophic adipose tissue and high secretion of TNFα and monocyte chemoattractant protein-1 from WAT. Finally, twist1 silencing in human adipocytes enhanced TNFα-induced monocyte chemoattractant protein-1 expression and secretion, which was paralleled by an increase in the mRNA expression of the nuclear factor-κB gene RelA. CONCLUSIONS: Low twist1 expression in human WAT correlates with obesity and an insulin-resistant phenotype, which may be mediated by an increased sensitivity to the proinflammatory effect of TNFα.
CONTEXT: Twist1 is a transcription factor implicated in the regulation of TNFα signaling and was recently shown to be highly expressed in both human and murine adipose tissue, but its role in obesity is unknown. OBJECTIVE: Our objective was to assess the expression of twist1 in human white adipose tissue (WAT), its relationship to obesity and insulin sensitivity, and how it modifies TNFα-mediated inflammation in adipocytes. PROCEDURE: Twist mRNA levels were measured in WAT from 130 nonobese and obese subjects, and its relation to clinical parameters was assessed. Twist1 expression was measured before and after weight loss as well as in different adipose regions. Human in vitro differentiated adipocytes were treated with TNFα under control conditions or after twist1 gene silencing by RNA interference. Gene expression and secretion of proinflammatory proteins were measured. RESULTS:Twist1 expression was low in obese subjects and increased after weight loss. Twist1 mRNA levels correlated with adiponectin levels and inversely with insulin resistance as well as adipocyte volume (P < 0.001 for all). Low twist1 expression associated with a hypertrophic adipose tissue and high secretion of TNFα and monocyte chemoattractant protein-1 from WAT. Finally, twist1 silencing in human adipocytes enhanced TNFα-induced monocyte chemoattractant protein-1 expression and secretion, which was paralleled by an increase in the mRNA expression of the nuclear factor-κB gene RelA. CONCLUSIONS: Low twist1 expression in human WAT correlates with obesity and an insulin-resistant phenotype, which may be mediated by an increased sensitivity to the proinflammatory effect of TNFα.
Authors: Hui Gao; Niklas Mejhert; Jackie A Fretz; Erik Arner; Silvia Lorente-Cebrián; Anna Ehrlund; Karin Dahlman-Wright; Xiaowei Gong; Staffan Strömblad; Iyadh Douagi; Jurga Laurencikiene; Ingrid Dahlman; Carsten O Daub; Mikael Rydén; Mark C Horowitz; Peter Arner Journal: Cell Metab Date: 2014-05-22 Impact factor: 27.287
Authors: Meghan L Ruebel; Matthew Cotter; Clark R Sims; Dean M Moutos; Thomas M Badger; Mario A Cleves; Kartik Shankar; Aline Andres Journal: J Clin Endocrinol Metab Date: 2017-06-01 Impact factor: 5.958
Authors: Annie M L Pettersson; Juan R Acosta; Christel Björk; Johan Krätzel; Britta Stenson; Lennart Blomqvist; Nathalie Viguerie; Dominique Langin; Peter Arner; Jurga Laurencikiene Journal: Diabetologia Date: 2015-06-27 Impact factor: 10.122
Authors: S Lallukka; K Sevastianova; J Perttilä; A Hakkarainen; M Orho-Melander; N Lundbom; V M Olkkonen; H Yki-Järvinen Journal: Diabetologia Date: 2013-01-19 Impact factor: 10.122
Authors: Banumathi K Cole; Margaret A Morris; Wojciech J Grzesik; Kendall A Leone; Jerry L Nadler Journal: Mediators Inflamm Date: 2012-12-27 Impact factor: 4.711